193 related articles for article (PubMed ID: 23455522)
21. Radioiodine uptake in an ovarian mature teratoma detected with SPECT/CT.
Yazici B; Oral A; Omur O; Yazici A
Clin Nucl Med; 2015 Feb; 40(2):e157-60. PubMed ID: 25140551
[TBL] [Abstract][Full Text] [Related]
22. Multifocal hot spots demonstrated by whole-body 131I scintigraphy and SPECT/CT after transaxillary endoscopic thyroidectomy.
Kim HS; Kim SH; Kim JH; Kim BT; Lee KH
Clin Nucl Med; 2015 Mar; 40(3):260-2. PubMed ID: 25642914
[TBL] [Abstract][Full Text] [Related]
23. The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer.
Grewal RK; Tuttle RM; Fox J; Borkar S; Chou JF; Gonen M; Strauss HW; Larson SM; Schöder H
J Nucl Med; 2010 Sep; 51(9):1361-7. PubMed ID: 20720058
[TBL] [Abstract][Full Text] [Related]
24. 131I Whole-Body Scan Incidental Uptake Due to Spermatocele.
Albano D; Motta F; Baronchelli C; Lucchini S; Bertagna F
Clin Nucl Med; 2017 Nov; 42(11):901-904. PubMed ID: 28902733
[TBL] [Abstract][Full Text] [Related]
25. Sustained and diffuse 131I avid bone metastases with low thyroglobulin levels in a patient with papillary thyroid carcinoma.
Zhao CL; Qiu ZL; Chen LB; Yuan ZB; Luo QY
Clin Nucl Med; 2013 May; 38(5):375-7. PubMed ID: 23567283
[TBL] [Abstract][Full Text] [Related]
26. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.
Spanu A; Solinas ME; Chessa F; Sanna D; Nuvoli S; Madeddu G
J Nucl Med; 2009 Feb; 50(2):184-90. PubMed ID: 19164225
[TBL] [Abstract][Full Text] [Related]
27. Clinical applications of single-photon emission computed tomography/computed tomography in post-ablation
Jiang L; Xiang Y; Huang R; Tian R; Liu B
Pediatr Radiol; 2021 Aug; 51(9):1724-1731. PubMed ID: 33759024
[TBL] [Abstract][Full Text] [Related]
28. Unusual case of adrenal and renal metastases from papillary carcinoma of thyroid.
Malhotra G; Upadhye TS; Sridhar E; Asopa RV; Garde PS; Gawde S; Rangarajan V
Clin Nucl Med; 2010 Sep; 35(9):731-6. PubMed ID: 20706057
[TBL] [Abstract][Full Text] [Related]
29. Intravenous Tumor Thrombus From Papillary Carcinoma of Thyroid Demonstrated by 18F-FDG PET/CT.
Wang Y; Jiang L; Zhang X; Xu Y; Liu B
Clin Nucl Med; 2022 Jun; 47(6):541-542. PubMed ID: 35025802
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes and prognostic factors of radioiodine ablation therapy for lymph node metastases from papillary thyroid carcinoma.
Wu X; Gu H; Gao Y; Li B; Fan R
Nucl Med Commun; 2018 Jan; 39(1):22-27. PubMed ID: 29135721
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of (99m)Tc-pertechnetate whole body scan with neck and chest SPECT/CT for detection of post-surgical thyroid remnant and metastasis in differentiated thyroid cancer patients.
Chantadisai M; Kingpetch K
Ann Nucl Med; 2014 Aug; 28(7):674-82. PubMed ID: 24889127
[TBL] [Abstract][Full Text] [Related]
32. Detection of intraluminal tracheal metastasis of thyroid papillary carcinoma by 18F-FDG PET/CT.
Ozkan E; Araz M; Soydal C; Kucuk NO; Ibis E
Clin Nucl Med; 2012 Jun; 37(6):e160-1. PubMed ID: 22614217
[TBL] [Abstract][Full Text] [Related]
33. Renal Metastasis From Primary Thyroid Cancer on 131I and MRI Imaging.
Patel DR; Kamat BH; Farwell MD
Clin Nucl Med; 2017 Jan; 42(1):70-72. PubMed ID: 27846002
[TBL] [Abstract][Full Text] [Related]
34. Unusual case of isolated parasellar metastasis from carcinoma of thyroid.
Malhotra G; Asopa RV; Sridhar E
Clin Nucl Med; 2013 Feb; 38(2):145-8. PubMed ID: 23334134
[TBL] [Abstract][Full Text] [Related]
35. 18F-FDG PET/CT demonstration of a liver metastasis in a patient with papillary thyroid cancer.
Mosci C; McDougall IR; Jeffrey RB; Iagaru A
Clin Nucl Med; 2012 Sep; 37(9):e234-6. PubMed ID: 22889801
[TBL] [Abstract][Full Text] [Related]
36. Anthracofibrosis Manifesting as False-Positive Iodine Accumulation in a Patient With Recent History of Thyroid Carcinoma.
Licht K; Kroegel C; Katenkamp K; Freesmeyer M
Clin Nucl Med; 2016 Apr; 41(4):336-7. PubMed ID: 26571446
[TBL] [Abstract][Full Text] [Related]
37. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
38. Pre-operative prediction of cervical nodal metastasis in papillary thyroid cancer by 99mTc-MIBI SPECT/CT; a pilot study.
Tangjaturonrasme N; Vasavid P; Sombuntham P; Keelawat S
J Med Assoc Thai; 2013 Jun; 96(6):696-702. PubMed ID: 23951827
[TBL] [Abstract][Full Text] [Related]
39. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
40. I-131 Postablation SPECT/CT Predicts Relapse of Papillary Thyroid Carcinoma more Accurately than Whole Body Scan.
Malamitsi JV; Koutsikos JT; Giourgouli SI; Zachaki SF; Pipikos TA; Vlachou FJ; Prassopoulos VK
In Vivo; 2019; 33(6):2255-2263. PubMed ID: 31662565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
